WitrynaCorrespondence: Mohd Makmor-Bakry, Faculty of Pharmacy, Universiti Kebangsaan Malaysia Kuala Lumpur, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, 50300, Malaysia, Tel +603 9289 7244, Fax +603 2698 3271, Email [email protected]. Purpose: The occurrence of drug-related problems (DRPs) and their causes …
FY2015 Regulatory Science Research Report: Narrow …
Witryna22 lis 2024 · Small changes in bioavailability of narrow therapeutic index (NTI) drugs can alter clinical outcomes, raising concern over generic NTI substitution. We surveyed pharmacists to identify their perceptions of generic NTI drugs, their frequency of performing generic NTI substitution, and predictors of this behavior. Witryna15 mar 2010 · Objective: To investigate how, and to what extent drugs, with a narrow therapeutic index (NTI-drugs), as compared with other drugs, relate to different types of drug-related problems (DRPs) in... grand prix new product awards
Narrow therapeutic index drugs: a clinical pharmacological ...
WitrynaNarrow Therapeutic Index (NTI) Medications. According to the FDA, narrow therapeutic index medications are those drugs “where small differences in dose or blood concentration may lead to serious therapeutic failures and/or adverse drug reactions that are life-threatening or result in persistent or significant disability or incapacity ... Witrynaa narrow therapeutic index (NTI). The decision whether to conduct a FIH trial in healthy volunteers or patients should be carefully considered and fully justified on a case-by-case basis. What is the starting dose for FIH? The most critical decision will be to determine the starting dose for FIH. Obviously, the dose needs to be low WitrynaThere are reported issues with generic substitutions of phenytoin, topiramate, levetiracetam, carbamazepine, and lamotrigine. There is discussion in the epilepsy community about additional guidelines, including designation of generic ASMs as Narrow Therapeutic Index (NTI) drugs and how patient education plays a role in generic … grand prix multiply